Categoría
Top Descargas
Iniciar sesión
Registrarse
Subir
Búsqueda
Categoría
Top Descargas
Iniciar sesión
Registrarse
Búsqueda
Home
Categories
Cost Benefit Analysis
Cost Benefit Analysis
Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia
Economics / Colombia / Cancer / Australia / Quality of life / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool / Risk / Forecasting / Argentina / Treatment Outcome / Decision Analysis / Health Policy / Pharmacoeconomics / Adolescent / Prevention / Israel / Biological Sciences / Decision Trees / Humans / Child / Age / Pneumonia / Young Adult / Infant / Vaccine / Cost effectiveness / Life Expectancy / Incidence / Vaccination / Discount Rate / Risk factors / Newborn Infant / Aged / Middle Aged / Quality adjusted life years / Adult / Economic Models / Cost Benefit Analysis / Retrospective Studies / Age Factors / Economic evaluation / Influenza Vaccine / Risk Factors / Vaccine Effectiveness / Older Adult / Cost of Illness / Health Care Costs / Age Groups / Nino / Immunization Programs / Child preschool
Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam
Public Health / Vietnam / Urban Health / Rural Health / Humans / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area
Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam
Public Health / Vietnam / Urban Health / Rural Health / Humans / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area / Low Birth Weight / Developing Country / Female / Male / Infant / Cost effectiveness / Incidence / Newborn Infant / Cost Benefit Analysis / Primary Prevention / Urban Area
Principales aspectos metodológicos en la Evaluación de Tecnologías Sanitarias
Evidence Based Medicine / Humans / Cost Benefit Analysis
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las guías europeas de prevención cardiovascular 2012
Diet / Public Health / Spain / Humans / Smoking Cessation / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
Diet / Public Health / Spain / Humans / Smoking Cessation / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention
Comentarios del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC) a las Guías Europeas de Prevención Cardiovascular 2012
Diet / Public Health / Spain / Humans / Smoking Cessation / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention / Europe / Risk factors / Neurologia / Theoretical Models / Adult / Public health systems and services research / Cost Benefit Analysis / Age Factors / Cardiovascular Diseases / Risk Factors / Neurología / Primary Prevention
Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock
Nursing / Cardiology / Treatment Outcome / Critical Care / Critical Care Medicine / Electrocardiography / Canada / Hypothermia / Humans / CS / Left Ventricular Assist Device / Female / Resuscitation / Male / Lung Diseases / Act / Refractory / Anesthesia / Perfusion / Clinical Sciences / Aged / Middle Aged / Adult / Surface Area / Public health systems and services research / Cost Benefit Analysis / Retrospective Studies / Prognosis / Chest / Intensive Care Medicine / Coronary Circulation / Centrifugal Pump / Hospital Mortality / Health Care Costs / Diabetic ketoacidosis / Lactic Acid / Logistic Models / Monte Carlo Method / Oxygenation / Thoracic and cardiovascular surgery / Heart Diseases / Extracorporeal Membrane Oxygenation / Assistive Device / Electrocardiography / Canada / Hypothermia / Humans / CS / Left Ventricular Assist Device / Female / Resuscitation / Male / Lung Diseases / Act / Refractory / Anesthesia / Perfusion / Clinical Sciences / Aged / Middle Aged / Adult / Surface Area / Public health systems and services research / Cost Benefit Analysis / Retrospective Studies / Prognosis / Chest / Intensive Care Medicine / Coronary Circulation / Centrifugal Pump / Hospital Mortality / Health Care Costs / Diabetic ketoacidosis / Lactic Acid / Logistic Models / Monte Carlo Method / Oxygenation / Thoracic and cardiovascular surgery / Heart Diseases / Extracorporeal Membrane Oxygenation / Assistive Device
Evaluación económica de la terapia de resincronización cardiaca
Electrophysiology / Cost Benefit Analysis
Evaluación económica de la terapia de resincronización cardiaca
Electrophysiology / Cost Benefit Analysis
Organización Nacional de Trasplante de Venezuela: a new initiative to approach donation and transplantation in our country
Health Education / Venezuela / Adolescent / Nonprofit Organizations / Humans / Program Development / Female / Organ Transplantation / Male / Attitude / Aged / Middle Aged / Adult / Cost Benefit Analysis / Program Development / Female / Organ Transplantation / Male / Attitude / Aged / Middle Aged / Adult / Cost Benefit Analysis
Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial
Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial
Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)
Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial
Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)
Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic
1
2
3
4
5
»
Copyright © 2017 DATOSPDF Inc.